secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2023-10-12T23:59:59+00:00
Accession:  0001104659-23-108759
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura receives $250K loan from controlling shareholder; warns cash only covers ops through late Nov 2023
--------------------------------------------------------------------------------

- Loan from AD Pharma (owns ~66% of Acura) increases aggregate principal to $4.42M at 5.25% interest, matures Dec 31, 2023.
- Proceeds expected to fund operations only through late November 2023; no assurance of additional financing.
- If unable to secure additional financing, company may need to scale back operations or seek bankruptcy protection.
- AD Pharma is controlled by Mr. Schutte, who also directly owns ~14% of Acura's outstanding common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465923108759/0001104659-23-108759-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465923108759/tm2328285d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-108759

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer